Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Rab11 family-interacting protein 2 is a cytosolic effector protein encoded by the RAB11FIP2 gene, primarily involved in the regulation of vesicular trafficking, particularly in the transport of vesicles from the endosomal recycling compartment to the plasma membrane[1][2][3]. It interacts directly with Rab11 GTPases—most notably Rab11A, Rab25, and MYO5B—to coordinate actin cytoskeleton remodeling, phagocytosis, exocytosis, and receptor-mediated endocytosis[2][3][6]. RAB11FIP2 forms homodimers through its C-terminal coiled-coil domain and contributes to maintaining cell polarity, vesicle recycling, and the regulation of endosomal trafficking in epithelial and other cell types[1][2]. Dysfunction or altered expression of RAB11FIP2 has been implicated in pathological processes such as cancer cell migration and invasion and rare congenital disorders, but it is not currently considered a therapeutic target for any approved drug[7][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Rab11 family-interacting protein 2 (RAB11FIP2).